PITTSBURGH, May 12, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (NASDAQ:XAGE) ("Longevity" or the "Company"), a bio-aesthetics company focused on longevity and healthy aging, today announced that it has resolved to effect a reverse stock split of the Company's common stock and has determined the ratio to be 1-for-30. The Company's stockholders approved the reverse stock split and granted the Longevity board of directors the authority to determine the exact split ratio and when to proceed with the reverse stock split at the Company's Special Meeting of Stockholders held on March 24, 2025. The reverse stock split became effective on May 12, 2025, at 9:00 a.m., Eastern Time (t

PITTSBURGH, Pa. & GAITHERSBURG, Md., April 14, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (NASDAQ:XAGE), a company focused on human longevity and healthy aging through technologically innovative and clinically proven products in regenerative bio-aesthetics, diagnostics, and nutrition ("Longevity", the "Company", "we", "our", or "us"), today announced the execution of a merger agreement (the "Merger") with 20/20 BioLabs, Inc. ("20/20"), a leading provider of innovative laboratory tests for the early detection and the proactive management of chronic disease risk, to combine the companies in an all-stock transaction. Following the closing of the Merger (the "Closing"), the combi

424B3 - Longevity Health Holdings, Inc. (0001842939) (Filer)

8-K - Longevity Health Holdings, Inc. (0001842939) (Filer)

S-4 - Longevity Health Holdings, Inc. (0001842939) (Filer)

424B3 - Longevity Health Holdings, Inc. (0001842939) (Filer)

424B5 - Longevity Health Holdings, Inc. (0001842939) (Filer)

8-K - Longevity Health Holdings, Inc. (0001842939) (Filer)

POS AM - Longevity Health Holdings, Inc. (0001842939) (Filer)

424B3 - Longevity Health Holdings, Inc. (0001842939) (Filer)

8-K - Longevity Health Holdings, Inc. (0001842939) (Filer)

424B3 - Longevity Health Holdings, Inc. (0001842939) (Filer)